Knee gel injection eases arthritis pain in 387-Patient study
NCT ID NCT07193368
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a single injection of polyacrylamide hydrogel (Arthrosamid®) into the knee joint of 387 people with knee osteoarthritis. Researchers measured pain and physical function over 12 months. The goal was to see if the gel could reduce pain and improve everyday movement.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- polyacrylamide hydrogel (Arthrosamid®)
- What this could lead to
- If confirmed, this injection could offer a non-surgical option to ease knee pain and improve daily function for people with osteoarthritis.
- What could go wrong
- This was a retrospective study without a placebo group, so results may be less reliable. Long-term safety and effectiveness beyond 12 months are not yet known.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEGENERATIVE JOINT DISEASE OF THE KNEE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hacettepe University, Faculty of Medicine, Department of Sports Medicine
Ankara, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can discarded bone reveal the secrets to stronger bones?
- Can a Low-Carb diet ease knee pain? a study investigates racial differences
- Blocking knee blood vessels may offer new pain relief for severe osteoarthritis
- Which knee implant lasts longer? a Head-to-Head test
- Can a new shoulder implant restore Pain-Free movement?
- Can cutting carbs curb knee pain? a diet trial puts it to the test